AKISOSTEM BIOSTRATEGIES
Archisostem BioStrategies is a research and development company.
AKISOSTEM BIOSTRATEGIES
Industry:
Alternative Medicine Health Care Medical
Founded:
2019-02-28
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Total Employee:
251+
Status:
Active
Total Funding:
2 B KRW
Similar Organizations
ADITEC Vaccine Consortium
ADITEC vaccine consortium is a research institutions and biotech company.
BLISTER EXPRESS
BLISTER EXPRESS is a pharmaceutical research and development company.
Dream Company
Dream Company is a health care research and development company.
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
Joinn Laboratories
Joinn Laboratories (China) operates as a medicines development company.
T.Pharm
T.Pharm is the production, sales, research, and development of drugs.
Yuanmo Health
Yuanmo Health focuses on the construction of medical and health management system research and development.
Investors List
Mira Partners
Mira Partners investment in Series A - Akisostem BioStrategies
TAP Angel Partners
TAP Angel Partners investment in Series A - Akisostem BioStrategies
BlissVine Ventures
BlissVine Ventures investment in Series A - Akisostem BioStrategies
Seoul Techno Holdings
Seoul Techno Holdings investment in Series A - Akisostem BioStrategies
More informations about "Akisostem BioStrategies"
Akisostem BioStrategies - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... Series A - Akisostem BioStrategies — Seoul …See details»
Akisostem BioStrategies - Crunchbase
Archisostem BioStrategies is a research and development company.See details»
GC Cell, CDMO Contract With Akisostem BioStrategies - CMOCRO
Through this contract, GC Cell will conduct quality tests such as manufacturing, storage, and characterization of Akisostem's umbilical cord mesenchymal stem cells for approximately three …See details»
ACESOSTEM BIOSTRATEGIES INC. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ACESOSTEM BIOSTRATEGIES INC. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
AcesoStem Biostrategies - PitchBook
AcesoStem Biostrategies General Information Description. Developer of drugs and therapeutics intended to provide treatment for rotator cuff disease. The company's therapeutics are used in …See details»
Restem
About Us. Welcome to RESTEM. We are a leading clinical-stage biopharmaceutical company focused on the discovery and development of patient-specific, as well as off-the-shelf and …See details»
RePORT 〉 RePORTER - National Institutes of Health
Awardee Organization BIOSTRATEGIES, LC. Description. Abstract Text. PROJECT SUMMARY In this Direct-to-Phase II SBIR, BioStrategies LC proposes to advance the development of a …See details»
Series A - Akisostem BioStrategies - 2022-02-06 - Crunchbase
Feb 6, 2022 Akisostem BioStrategies raised $1668906 on 2022-02-06 in Series A. Start Free Trial . Chrome ExtensionSee details»
AcesoStem Biostrategies Stock Price, Funding, Valuation, Revenue ...
See AcesoStem Biostrategies funding rounds, investors, investments, exits and more. Evaluate their financials based on AcesoStem Biostrategies's post-money valuation and revenue.See details»
NIH Awards by Location & Organization - report.nih.gov
Note: Although this list can be sorted by the amount of funding each organization receives, these data should not be interpreted as a ranking of institutions by NIH. NIH's use of multiple …See details»
AcesoStem Biostrategies - Products, Competitors, Financials, …
AcesoStem Biostrategies specializes in patented technology related to the smumf cell, an umbilical cord-derived, regenerative medical platform cell that was transferred from the Seoul …See details»
AcesoStem Biostrategies Asset Profile - Preqin
AcesoStem Biostrategies developing therapy based on smump cell is an umbilical cord-derived cell without aging and low immunogenicity and high immunomodulatory ability even in a pro …See details»
Akisostem BioStrategies - Updates, News, Events, Signals & Triggers
Organization. Akisostem BioStrategies . Connect to CRM . Save . Summary Financials People Signals & News Similar Companies. Recent News & Activity. Edit Recent News & Activity …See details»
biostrategies Group Company Profile 2024: Valuation, Investors ...
Biostrategies Group General Information Description. Provider of consulting services catering to the biopharma industry. The company specializes in developing commercial strategies for new …See details»
Charles River Associates (CRA) Acquires bioStrategies Group, Inc.
Nov 29, 2022 Chris Schneider was a partner at bioStrategies Group and has more than 20 years of biopharma experience in a variety of commercial strategy and analytical roles on both the …See details»
The Bio Revolution: Innovations transforming economies, …
May 13, 2020 A confluence of advances in biological science and accelerating development of computing, automation, and artificial intelligence is fueling a new wave of innovation. This Bio …See details»
Mira Partners - Investments, Portfolio & Company Exits - Crunchbase
Feb 6, 2022 Which industries has this organization most actively invested in? Show . Announced Date . Organization Name . Lead Investor . Funding Round . Money Raised . Feb 6, 2022: …See details»
What is Bio Strategy? - Medium
Oct 20, 2017 The 2,000 year-old Go game is all strategy.Image source: Jaro Lanos. This is an excerpt from our forthcoming book What’s Your Bio Strategy? “At the dawn of the 21st …See details»
BlissVine Ventures - Investments, Portfolio & Company Exits
Feb 2, 2024 Which industries has this organization most actively invested in? Show . Announced Date . Organization Name . Lead Investor . Funding Round . Money Raised . Feb 2, 2024: ...See details»